Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001236933 | SCV001409674 | pathogenic | Wilson disease | 2022-09-18 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 1010 of the ATP7B protein (p.Lys1010Arg). This variant is present in population databases (rs747584649, gnomAD 0.007%). This missense change has been observed in individual(s) with Wilson disease (PMID: 17264425, 18698682, 30120852). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 962980). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ATP7B protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001236933 | SCV004216395 | likely pathogenic | Wilson disease | 2023-06-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001236933 | SCV002086832 | likely pathogenic | Wilson disease | 2020-03-27 | no assertion criteria provided | clinical testing |